These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 23152054)

  • 1. Autophagy as a new therapeutic target in Duchenne muscular dystrophy.
    De Palma C; Morisi F; Cheli S; Pambianco S; Cappello V; Vezzoli M; Rovere-Querini P; Moggio M; Ripolone M; Francolini M; Sandri M; Clementi E
    Cell Death Dis; 2012 Nov; 3(11):e418. PubMed ID: 23152054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perturbation of PI3K/Akt signaling affected autophagy modulation in dystrophin-deficient myoblasts.
    Yazid MD; Hung-Chih C
    Cell Commun Signal; 2021 Oct; 19(1):105. PubMed ID: 34706731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy.
    Morales MG; Gutierrez J; Cabello-Verrugio C; Cabrera D; Lipson KE; Goldschmeding R; Brandan E
    Hum Mol Genet; 2013 Dec; 22(24):4938-51. PubMed ID: 23904456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy.
    Terrill JR; Pinniger GJ; Graves JA; Grounds MD; Arthur PG
    J Physiol; 2016 Jun; 594(11):3095-110. PubMed ID: 26659826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy.
    Whitehead NP; Kim MJ; Bible KL; Adams ME; Froehner SC
    Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12864-9. PubMed ID: 26417069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin ameliorates dystrophic phenotype in mdx mouse skeletal muscle.
    Eghtesad S; Jhunjhunwala S; Little SR; Clemens PR
    Mol Med; 2011; 17(9-10):917-24. PubMed ID: 21607286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophy.
    Sinadinos A; Young CN; Al-Khalidi R; Teti A; Kalinski P; Mohamad S; Floriot L; Henry T; Tozzi G; Jiang T; Wurtz O; Lefebvre A; Shugay M; Tong J; Vaudry D; Arkle S; doRego JC; Górecki DC
    PLoS Med; 2015 Oct; 12(10):e1001888. PubMed ID: 26461208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ifetroban reduces coronary artery dysfunction in a mouse model of Duchenne muscular dystrophy.
    Mitchell R; Frederick NE; Holzman ER; Agobe F; Allaway HCM; Bagher P
    Am J Physiol Heart Circ Physiol; 2021 Jul; 321(1):H52-H58. PubMed ID: 34048282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Src-dependent impairment of autophagy by oxidative stress in a mouse model of Duchenne muscular dystrophy.
    Pal R; Palmieri M; Loehr JA; Li S; Abo-Zahrah R; Monroe TO; Thakur PB; Sardiello M; Rodney GG
    Nat Commun; 2014 Jul; 5():4425. PubMed ID: 25028121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of muscular dystrophy, exercise and blocking activin receptor IIB ligands on the unfolded protein response and oxidative stress.
    Hulmi JJ; Hentilä J; DeRuisseau KC; Oliveira BM; Papaioannou KG; Autio R; Kujala UM; Ritvos O; Kainulainen H; Korkmaz A; Atalay M
    Free Radic Biol Med; 2016 Oct; 99():308-322. PubMed ID: 27554968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism.
    Al-Khalidi R; Panicucci C; Cox P; Chira N; Róg J; Young CNJ; McGeehan RE; Ambati K; Ambati J; Zabłocki K; Gazzerro E; Arkle S; Bruno C; Górecki DC
    Acta Neuropathol Commun; 2018 Apr; 6(1):27. PubMed ID: 29642926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of AKT signaling promotes cell growth and survival in α7β1 integrin-mediated alleviation of muscular dystrophy.
    Boppart MD; Burkin DJ; Kaufman SJ
    Biochim Biophys Acta; 2011 Apr; 1812(4):439-46. PubMed ID: 21216283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-body clearing, staining and screening of calcium deposits in the mdx mouse model of Duchenne muscular dystrophy.
    Bozycki L; Łukasiewicz K; Matryba P; Pikula S
    Skelet Muscle; 2018 Jul; 8(1):21. PubMed ID: 30025544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microtubules underlie dysfunction in duchenne muscular dystrophy.
    Khairallah RJ; Shi G; Sbrana F; Prosser BL; Borroto C; Mazaitis MJ; Hoffman EP; Mahurkar A; Sachs F; Sun Y; Chen YW; Raiteri R; Lederer WJ; Dorsey SG; Ward CW
    Sci Signal; 2012 Aug; 5(236):ra56. PubMed ID: 22871609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
    Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
    Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural disease history of the D2
    van Putten M; Putker K; Overzier M; Adamzek WA; Pasteuning-Vuhman S; Plomp JJ; Aartsma-Rus A
    FASEB J; 2019 Jul; 33(7):8110-8124. PubMed ID: 30933664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle.
    Joassard OR; Amirouche A; Gallot YS; Desgeorges MM; Castells J; Durieux AC; Berthon P; Freyssenet DG
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2444-55. PubMed ID: 23916784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulated Autophagy and Mitophagy in a Mouse Model of Duchenne Muscular Dystrophy Remain Unchanged Following Heme Oxygenase-1 Knockout.
    Mucha O; Kaziród K; Podkalicka P; Rusin K; Dulak J; Łoboda A
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcolipin deletion in mdx mice impairs calcineurin signalling and worsens dystrophic pathology.
    Fajardo VA; Chambers PJ; Juracic ES; Rietze BA; Gamu D; Bellissimo C; Kwon F; Quadrilatero J; Russell Tupling A
    Hum Mol Genet; 2018 Dec; 27(23):4094-4102. PubMed ID: 30137316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.